Gender- and age-related differences in the endocrine parameters of acromegaly

Journal of Endocrinological Investigation

Volumn 25, Issue 6, 2002, Pages 532-538

  Colao, Annamaria ^a   Amato, G ^a   Pedroncelli, A M ^b   Baldelli, R ^c   Grottoli, S ^d   Gasco, V ^d   Petretta, M ^a   Pagani, G ^b   Tamburano, G ^c   Lombardi, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

Acromegaly; Age; Aging; Gender; GH; IGF I; Pituitary adenomas

Indexed keywords

HUMAN GROWTH HORMONE; SOMATOMEDIN C; GLUCOSE; GROWTH HORMONE;

ACROMEGALY; ADENOMA; ADULT; AGED; AGING; ARTICLE; BLOOD; COHORT ANALYSIS; DIET RESTRICTION; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; HYPOPHYSIS TUMOR; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RETROSPECTIVE STUDY; SEXUAL DEVELOPMENT; AGE; BASAL METABOLIC RATE; CANCER SIZE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; GERIATRIC PATIENT; HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; PROGNOSIS; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ACROMEGALY; ADENOMA; ADULT; AGED; AGING; COHORT STUDIES; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS; HUMAN; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T;

EID: 0035987931     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03345496     Document Type: Article

References (33)

1. Growth-hormone and prolactin excess
2. Acromegaly
3. Recent advances in pathogenesis, diagnosis and management of acromegaly
4. Pituitary tumors in the elderly
5. Clinical and medical diagnosis of acromegaly
6. An audit of outcome of treatment in acromegaly
7. Epidemiology and long term survival in acromegaly
8. Mortality and cancer incidence in acromegaly: A retrospective cohort study
9. Determinants of clinical outcome and survival in acromegaly
10. Mortality in acromegaly
11. New approach to the diagnosis of growth hormone deficiency in adults
12. The influence of age on the 24 hour integrated concentration of growth hormone in normal individuals
13. Criteria for cure of acromegaly: A consensus statement
14. GH response to oral and intravenous glucose load in acromegalic patients
15. Current treatment guidelines for acromegaly
16. Pituitary tumours in the elderly: A 20 year experience
17. The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: Influence of age and sex
18. Effects of estrogen and sex difference on secretion of human growth hormone
19. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations
20. Growth hormone: Metabolic clearance rates, integrated concentrations, and production rates in normal adults and the effects of prednisone
21. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women
22. Gender difference in growth hormone response in adults
23. Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency
24. Menstrual irregularity in women with acromegaly
25. Prediction of efficacy of octreotide therapy in patients with acromegaly
26. Acromegaly
27. Sex difference in the relation between sellar volume and basal and GH-releasing hormone stimulated GH in acromegaly
28. Basal plasma growth hormone levels in man: New evidence for rhythmicity of growth hormone secretion
29. An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women
30. Sexual dimorphism of the somatotrophic axis
31. Regulatory mechanisms of growth hormone secretion are sexually dimorphic
32. Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women
33. Pharmacotherapy or surgery as primary treatment for acromegaly?